DRAXIN

Chr 1

dorsal inhibitory axon guidance protein

Also known as: AGPA3119, C1orf187, UNQ3119, neucrin

Enables molecular adaptor activity. Predicted to be involved in negative regulation of canonical Wnt signaling pathway and nervous system development. Predicted to act upstream of or within negative regulation of axon extension and negative regulation of neuron apoptotic process. Predicted to be active in extracellular region. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…
0
Active trials
5
Pubs (1 yr)
P/LP submissions
P/LP missense
1.53
LOEUF
Mechanism

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.53LOEUF
pLI 0.000
Z-score 0.02
OE 1.00 (0.671.53)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
1.32Z-score
OE missense 0.75 (0.660.85)
161 obs / 215.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?1.00 (0.671.53)
00.351.4
Missense OE?0.75 (0.660.85)
00.61.4
Synonymous OE?0.86
01.21.6
LoF obs/exp: 15 / 15.1Missense obs/exp: 161 / 215.6Syn Z: 1.06

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

DRAXIN · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →